Table 2. Results of the multiple regression analysis (independent variable: Overall guideline quality).
Predictors | Unstandardized coefficients | 95% confidence interval for B | t | P-value | Adjusted P-value (sig. < 0.05) | ||
---|---|---|---|---|---|---|---|
B | Standard error | Lower bound | Upper bound | ||||
Intercept | 5.591 | 1.753 | 3.19 | 0.001 | |||
Domain 1 (scope and purpose) | .175 | 0.026 | .125 | .226 | 6.784 | < 0.001 | < 0.001 |
Domain 2 (stakeholder involvement) | .062 | 0.026 | .011 | .114 | 2.381 | 0.018 | 0.018 |
Domain 3 (rigour of development) | .300 | 0.025 | .250 | .350 | 11.796 | < 0.001 | < 0.001 |
Domain 4 (clarity of presentation) | .203 | 0.027 | .150 | .255 | 7.583 | < 0.001 | < 0.001 |
Domain 5 (applicability) | .163 | 0.021 | .123 | .204 | 7.913 | < 0.001 | < 0.001 |
Domain 6 (editorial independence) | .065 | 0.017 | .032 | .099 | 3.841 | < 0.001 | < 0.001 |
Dependent variable: overall guideline quality; adjusted R2: 0.732